ArticleFrontiers in oncology2025

Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY Trial.

Mark Hensley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.